Allied Market Research
Upcoming Allied Market Research
Nanotechnology Drug Delivery Market

Nanotechnology Drug Delivery Market: Global Opportunity Analysis and Industry Forecast, 2022-2029

Pages: NA
May 2022 | 736 Views
Author(s) : NA
Tables: NA
Charts: NA
  • Formats*:

  • SIngle User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • IComes with the additional cost
    of $2500.00 contact sales.



Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Nanotechnology Drug Delivery Market

Request Now !

Nanotechnology used in medicine which manipulate the molecule such as on an atomic, molecular, and supramolecular scale and developed many new materials and devices with a vast range of applications, including nanomedicine, nanoelectronics, biomaterials energy production, and consumer products. Nanotechnology is most widely used to treat disease and prevent health issues. Nanotechnology in drug delivery development is the use of nanoparticles to deliver drugs to cancer cells. Nanotechnology Drug Delivery refers to the usage of nanoscale healthcare materials and technology in pharmaceutical drug delivery to improve the efficacy of the drug. Nanotechnology drug delivery is broadly used in the health care industry in applications such as neurology, anti-infective, cardiovascular disorders, and others. Most widely used in application area of nanotechnology drug delivery systems is to transport drugs to the final location of therapeutic intervention within the body. Nanotechnology drug delivery is a growing field in pharmaceutical industry and it contribute largest market share which rising adoption in health care applications. The nanotechnology drug delivery market is rapid growth due to increase in research and development activities in nanotechnology to develop novel nano-medicine.


Market scope and structure analysis:

Report Metric


  Market size available for years


  Base year considered


  Forecast period


  Forecast units

  Value ($USD)

  Segments covered

  Technology, Application

  Region covered

North America (U.S., and Canada), Europe (U.K, France, Italy, Spain and Rest of Europe), Asia-Pacific (China, India, Japan, Australia and Rest of Asia-Pacific), LANTAM (Brazil, Argentina and Rest of Latin America), Middle East & Africa (South Africa and  GCC)

  Companies covered

Major players analyzed include, Taiwan Liposome Company, Nanobiotix, NanoCarrier  Corporation  ltd, Tarveda Therapeutics, Aquanova AG, AbbVie, Inc., Amgen, Inc., Celgene Corporation, Johnson & Johnson, Merck & Co., Inc., and Novartis International AG,


COVID-19 Scenario Analysis:

Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicines supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as Hydroxychloroquine have witnessed dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunity for manufacturers of COVID-19 management drugs, as many developed countries are short of these drugs. Owing to the demand for vaccine and treatment drugs for COVID-19, the pharmaceutical and biotechnology industry is expected to witness a significant growth in the future.

Ongoing spread of COVID-19 impacted the growth of nanotechnology drug delivery market. Multidrug nanoparticles for the targeted delivery of drugs could be used to combat inflammation in COVID-19 patients, say researchers. Nano-based products are currently being developed for the control, diagnosis, and treatment of COVID-19. The nanotechnology used in COVID-19 have various feature such as Improved and virus disabling air filtration, Low-cost, scalable detection methods for the detection of viral particles, Enhanced personal protection equipment (PPE) including facemasks, New antiviral vaccine and drug delivery platforms, New therapeutic solutions, etc., which enhance the growth of nanotechnology drug delivery market.

Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis:

Globally, North America is the most dominance region in the nanotechnology drug delivery market due to the well-developed hospital facilities, presence of advanced technology and increasing incidence of chronic diseases such as cardiovascular diseases (CVD) and cancer. However, Europe is considered as a second largest share of the market due to the increasing number of pharmaceutical and biotechnology manufacturers owing to affordability for branded nanotechnology products by consumers. Whereas Asia-Pacific expected contribute market growth rate due to the increasing patient population and rising demand for nanotechnology drug product to treat the chronic diseases. 

In 2018, “National Cancer Institute”, state that around 1.73 million new cases of cancer will be diagnosed in the United States and more than 600,000 people died from the disease. In 2018, “World Health Organization” reported that due to the cardiovascular disease (CVD) around 24% of patient deaths was found in 2016 in Mexico. According to the “American Heart Association” reported that in 2016, around 840,678 deaths happened in US due to the Cardiovascular diseases which rising the demand for novel nanotechnology drug delivery technology.

The factor that drive the growth of nanotechnology drug delivery market such as growing awareness amongst the people regarding nanotechnology, increasing incidence of chronic diseases, rising government initiatives, and increasing demand for novel drug delivery,  increasing technological advancements, rising investment in nanotechnology. However, the factor such as high cost of medicines associated with nanotechnology and stringent government regulation are likely to restrain the growth of market 

New Product launch to flourish the market:

Major Key market manufacturer have been focusing on producing new product solution for specific applications as there are varying demands based on the utilization. Leading market players have determined how improved accuracy can be influential in many applications. In 2019, Taiwan Liposome Company has launched “LipAD“(Proprietary Lipid-Assembled Drug Delivery Platforms) TLC. This product creating solutions for long-lasting challenges in drug development by enabling new therapies with entirely unique properties. In 2018, “Nanobiotix”, has launched new drug product such as “Hensify®”. This is first-in-class product which introducing a new, physical mechanism of action and designed to physically destroy tumors and activate the immune system for both local control and systemic disease treatment when combined with radiation therapy. For instance, in 2011–2012, Pfizer, Inc., Amgen, Inc., and AstraZeneca signed agreements to collaborate with BIND Therapeutics to develop nano-medicines. These initiatives are expected to fuel the growth of the nanotechnology drug delivery market in the near future.

Key segments covered:




  • Nanocrystal
  • Nanoparticle
  • Liposome
  • Micelles
  • others


  •  Neurology
  • Oncology
  • Cardiovascular
  • Anti-inflammatory
  • Anti-infective


Key benefits of the report:

  • This study presents the analytical depiction of the global nanotechnology drug delivery market along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global nanotechnology drug delivery market share.
  • The current market is quantitatively analyzed from 2020 to 2027 to highlight the global nanotechnology drug delivery market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed global nanotechnology drug delivery market analysis based on competitive intensity and how the competition will take shape in coming years.

Questions answered in the Nanotechnology Drug Delivery Market research report:

  • Who are the leading market players active in nanotechnology drug delivery market?
  • What are the current trends will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the market?
  • What are the projections for the future that will help in taking further strategic steps?

Key Market Segments

Segments Sub-segments
By Technology
  • Nanocrystal
  • Nanoparticle
  • Liposome
  • Micelles
  • Others
By Application
  • Neurology
  • Oncology
  • Cardiovascular
  • Anti-inflammatory
  • Anti-infective
By Region
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • UK
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA

Key Market Players

  • Taiwan Liposome Company
  • Nanobiotix
  • NanoCarrier Corporation ltd
  • Tarveda Therapeutics
  • Aquanova AG
  • AbbVie, Inc.
  • Amgen, Inc.
  • Celgene Corporation
  • Johnson and Johnson
  • Merck and Co., Inc.
  • Novartis International AG,
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

Start reading ,This Report and over 13000+ thousand more Reports, Available with Avenue Library, T&C*

Call or Email us

Toll-free :
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email :
Allied Market Research Allied Market Research Allied Market Research

Access from any device, anywhere

Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.










Purchase Full Report of
Nanotechnology Drug Delivery Market

Start reading.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,456
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $5,769
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,450
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise

  • $9,995
  • Unlimited
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
  • Company Profiles
  • Newly Added Content Access
  • 10 PDF
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD


Why Allied Market Research?


Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save time of readers


Featured Reports


Erythropoietin Drugs Market

Global Opportunity Analysis and Industry Forecast, 2021–2028

Published in May 2021

Download Sample

Protein Therapeutics Market

Global Opportunity Analysis and Industry Forecast, 2021–2030

Published in Feb 2022

Download Sample

Surgical Equipment Market

Global Opportunity Analysis and Industry Forecast, 2020-2027

Published in Jan 2021

Download Sample

Medical Implant Market

Global Opportunity Analysis and Industry Forecast, 2020–2027

Published in Nov 2020

Download Sample

Featured Readings


Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?


Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save time of readers